Knight Therapeutics Inc

Business address
3400 Boulevard De Maisonneuve West, Suite 1055, Montreal, Quebec, Canada, H3Z 3B8
Top holdings (ownership)
SYNR and SXTP
State of incorporation
Quebec, Canada
Fiscal year end
31 December
Get insider transactions for this reporting owner
Knight Therapeutics Inc has filed 9 SEC EDGAR filings since 17 Oct 2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G/A Open Document Open Filing 13 Jun 2025
4 Open Document Open Filing 13 Jun 2025 11 Jun 2025 001-42374
SCHEDULE 13G Open Document Open Filing 20 Mar 2025
SC 13G/A Open Document Open Filing AMENDMENT NO. 2 TO SCHEDULE 13G 13 Nov 2024
3 Open Document Open Filing PRIMARY DOCUMENT 22 Oct 2024 22 Oct 2024 001-42374
4 Open Document Open Filing FORM 4 03 Apr 2024 28 Jul 2023 001-41719
3 Open Document Open Filing 18 Dec 2023 11 Jul 2023 001-41719
SC 13G/A Open Document Open Filing SC 13G/A 14 Feb 2019
SC 13G Open Document Open Filing SCHEDULE 13G 17 Oct 2018